James A. Geraghty, Director at Voyager Therapeutics, Inc. (VYGR), bought 6,000 shares at $18.31 ($110K) on 2018-08-17, disclosed to the SEC on 2018-08-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.31 | 3,000 | $55K | 50.0% |
| 2 | $18.31 | 3,000 | $55K | 50.0% |
| Total | $18.31 avg | 6,000 | $110K | 100% |
| Filing → |
| IDRA | BUY | 2018-08-08 | $56K | — | Filing → |
| PIRS | BUY | 2018-05-16 | $58K | — | Filing → |
| PIRS | BUY | 2017-08-17 | $48K | — | Filing → |